Thousands monitored: is the whooping cough vaccine safe in real life?
NCT ID NCT07444502
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tracked over 10,000 people in Thailand who received the Boostagen® vaccine, which protects against tetanus, diphtheria, and whooping cough. Healthcare workers reported any side effects to see how safe the vaccine is in everyday use. The study also looked at pregnant women and their newborns to check for any complications. The goal is to ensure the vaccine remains safe after being approved for the public.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Boostagen® (combined tetanus, diphtheria, and acellular pertussis vaccine)
What this could lead to
If successful, this study will confirm that Boostagen® is safe for widespread use, including in pregnant women, helping protect against whooping cough, tetanus, and diphtheria.
What could go wrong
This is an observational safety study, not a test of effectiveness. It may not detect rare side effects, and results are specific to Thailand's population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioNet-Asia Co., Ltd.
Bangkok, 10260, Thailand